title: Neonatal MeCP2 is important for the organization of sex differences in vasopressin expression.
abstract: Several neurodevelopmental disorders are marked by atypical Methyl-CpG-binding protein 2 (MeCP2) expression or function; however, the role of MeCP2 is complex and not entirely clear. Interestingly, there are sex differences in some of these disorders, and it appears that MeCP2 has sex-specific roles during development. Specifically, recent data indicate that a transient reduction in MeCP2 within developing amygdala reduces juvenile social play behavior in males to female-typical levels. These data suggest that MeCP2 within the amygdala is involved in programming lasting sex differences in social behavior. In the present study, we infused MeCP2 or control siRNA into the amygdala of male and female rats during the first three days of postnatal life in order to assess the impact of a transient reduction in MeCP2 on arginine vasopressin (AVP), a neural marker that is expressed differentially between males and females and is linked to a number of social behaviors. The expression of AVP, as well as several other genes, was measured in two-week old and adult animals. Two-week old males expressed more AVP and galanin mRNA in the amygdala than females, and a transient reduction in MeCP2 eliminated this sex difference by reducing the expression of both gene products in males. A transient reduction in MeCP2 also decreased androgen receptor (AR) mRNA in two-week old males. In adulthood, control males had more AVP-immunoreactive (AVP-ir) cells than females in the centromedial amygdala (CMA), bed nucleus of the stria terminalis (BST) and in the fibers that project from these cells to the lateral septum (LS). A transient reduction in MeCP2 eliminated this sex difference. Interestingly, there were no lasting differences in galanin or AR levels in adulthood. Reducing MeCP2 levels during development did not alter estrogen receptorα, neurofilament or Foxg1. We conclude that a transient reduction in MeCP2 expression in the developing male amygdala has a transient impact on galanin and AR expression but a lasting impact on AVP expression, highlighting the importance of MeCP2 in organizing sex differences in the amygdala.
authors.affiliation: Psychology Department, University of Wisconsin-Madison, Madison, WI, USA.
authors.forename: Robin M
authors.initials: RM
authors.lastname: Forbes-Lorman
authors.forename: Jared J
authors.initials: JJ
authors.lastname: Rautio
authors.forename: Joseph R
authors.initials: JR
authors.lastname: Kurian
authors.forename: Anthony P
authors.initials: AP
authors.lastname: Auger
authors.forename: Catherine J
authors.initials: CJ
authors.lastname: Auger
mesh_terms: D000679:Amygdala / Q000187:drug effects*; D000818:Animals; D000831:Animals, Newborn; D001127:Arginine Vasopressin / Q000378:metabolism*; D001522:Behavior, Animal / Q000187:drug effects; D005260:Female; D019004:Galanin / Q000378:metabolism; D005786:Gene Expression Regulation / Q000187:drug effects*; D020868:Gene Silencing; D008297:Male; D051783:Methyl-CpG-Binding Protein 2 / Q000235:genetics / Q000378:metabolism* / Q000494:pharmacology*; D034741:RNA, Small Interfering / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D011944:Receptors, Androgen / Q000378:metabolism; D012727:Sex Characteristics
chemical_list: D051783:Methyl-CpG-Binding Protein 2; D034741:RNA, Small Interfering; D011944:Receptors, Androgen; D001127:Arginine Vasopressin; D019004:Galanin